Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) EPS (Basic) (2016 - 2026)

Wave Life Sciences (WVE) has disclosed EPS (Basic) for 12 consecutive years, with -$0.13 as the latest value for Q1 2026.

  • For Q1 2026, EPS (Basic) rose 55.17% year-over-year to -$0.13; the TTM value through Mar 2026 reached -$1.05, down 41.89%, while the annual FY2025 figure was -$1.21, 72.86% down from the prior year.
  • EPS (Basic) hit -$0.13 in Q1 2026 for Wave Life Sciences, up from -$0.29 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.27 in Q4 2024 and bottomed at -$0.62 in Q1 2022.
  • Average EPS (Basic) over 5 years is -$0.28, with a median of -$0.29 recorded in 2025.
  • On a YoY basis, EPS (Basic) climbed as much as 280.0% in 2024 and fell as far as 771.43% in 2024.
  • Wave Life Sciences' EPS (Basic) stood at -$0.45 in 2022, then soared by 66.67% to -$0.15 in 2023, then skyrocketed by 280.0% to $0.27 in 2024, then tumbled by 207.41% to -$0.29 in 2025, then soared by 55.17% to -$0.13 in 2026.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.13, -$0.29, and -$0.32 for Q1 2026, Q4 2025, and Q3 2025 respectively.